Published by TMR Research Insights
Posted on August 16, 2021
5 min readLast updated: February 16, 2026
Add as preferred source on Google
A notable number of DES approvals by Food and Drug Administration, China Food and Drug Administration, Japanese Ministry of Health, and other such regulatory authorities is driving growth in the global drug-eluting stents market. Another factor which is critical in the market is increase in incidence of cardiovascular diseases.
As per Transparency Market Research, “The global drug-eluting stents market will grow at a compound annual growth rate of about 5% from 2019 to 2027, which will pull up its worth to about USD 8.3 billion by the end of the forecast period. Multiple growth factors such as increase in numbers of geriatric people, increase in research and development (R&D) activities and technological advancement are propelling the market forward.”
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30632
It is pertinent to note here that eating out frequently, consuming high levels of junk food, excessive smoking and drinking, and a sedentary and hectic lifestyle are driving up cases cardiovascular diseases. And, this is driving up the curve of de-eluting stents market.
Besides, older people are increasing in number as can be noted from the fact that by 2050, 2 billion people will be in 60s or over. In 2017, this was a small number of about 970 million and it was small percentage of total population. It is also important to note here that in the age group of 65 and above by the mentioned year, one in every six people across the globe will fall. Since, this demographic is susceptible to heart-related diseases, it will drive up the market for drug-eluting stents.
Additionally, development and adoption of new generation drug-eluting stents is paving way for higher demand for treatment of peripheral artery disease. Players are actively trying to improve products via innovation. This is an important factor of growth. This also ensures that technology and research and development hold a place of prominence in the market landscape.
Request for Analysis of COVID-19 Impact on Drug-eluting Stents Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=30632
North America to be a Prominent Region in the Global Drug-eluting Stents Market over the Forecast Period
From 2019 to 2027, North American region will chart significant growth and account for a dominant share of the global drug-eluting stents market. Numerous factors of growth will contribute to this market position. Some of these are impressive reimbursement policy, a large number of cases of cardiovascular diseases among its population, and rapidly ageing population – one in every four to be aged 65 and above by the year of 2050.
Besides, diseases such as obesity, diabetes, and other chronic illnesses are also being noted. In the United States of America, the figures for incidence of chronic illnesses are steep – six in every ten people suffer from one such illness. There is a massive prevalence of drinking and smoking as well. These factors are driving the region market upward and forward.
Another region that is set to show great promise over this period is Asia Pacific (APAC). Its compound annual growth rate will be about 6% from 2019 to 2027. Presence of a large number of older people and increase in government efforts towards improvement of healthcare outcomes is leading to growth in this region.
Buy Drug-eluting Stents Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=30632<ype=S
The Drug-eluting Stents Market to Witness Intense Competition over the Forecast Period
The slightly fragmented vendor landscape of global drug eluting stents market has a decent number of players marking its landscape. These are both active and ready to fight off the competition by opting for effective measures. Top players in the market include Boston Scientific Corporation, Medtronic, Abbott, Biosensors International Group, Ltd ( Bluesail Medical Co., Ltd.), Biotronik, MicroPort Scientific Corporation, Terumo Corporation, Cook, STENTYS SA, and Medinol Ltd, among others.
More Trending Reports by Transparency Market Research –
Hemorrhoid Treatment Devices Market: https://www.prnewswire.com/news-releases/global-hemorrhoid-treatment-devices-market-to-grow-at-over-4-6-cagr-from-2018-to-2026-transparency-market-research-301001722.html
Hepatitis Therapeutics Market: https://www.prnewswire.com/news-releases/hepatitis-therapeutics-market-public-concerns-of-morbidity-and-mortality-and-burden-on-healthcare-systems-of-hepatitis-steers-growth-market-projected-to-expand-at-2-3-cagr-from-2018–2026–tmr-301248274.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information, we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Transparency Market Research
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Blog: https://tmrblog.com/
Follow Us: Twitter | LinkedIn
Press Release Source: https://www.transparencymarketresearch.com/pressrelease/drug-eluting-stents-market.htm
The global drug-eluting stents market is expected to grow at a compound annual growth rate of about 5% from 2019 to 2027.
North America is anticipated to account for a dominant share of the global drug-eluting stents market during the forecast period.
Factors such as an increase in regulatory approvals, a rise in cardiovascular diseases, and the aging population are driving the growth of the drug-eluting stents market.
By 2050, it is estimated that 2 billion people will be aged 60 or over, up from about 970 million in 2017.
The Asia Pacific region is projected to have a compound annual growth rate of about 6% from 2019 to 2027.
Explore more articles in the Research Reports category
